Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0YA8C
|
||||
| Former ID |
DNC013206
|
||||
| Drug Name |
2-benzyl-N1-hydroxy-N3-(3-phenylpropyl)malonamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H22N2O3
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CCCNC(=O)C(CC2=CC=CC=C2)C(=O)NO
|
||||
| InChI |
1S/C19H22N2O3/c22-18(20-13-7-12-15-8-3-1-4-9-15)17(19(23)21-24)14-16-10-5-2-6-11-16/h1-6,8-11,17,24H,7,12-14H2,(H,20,22)(H,21,23)
|
||||
| InChIKey |
CQGGQNFRJIAPHA-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Aminopeptidase N | Target Info | Inhibitor | [1] | |
| BioCyc Pathway | Glutathione-mediated detoxification | ||||
| KEGG Pathway | Glutathione metabolism | ||||
| Metabolic pathways | |||||
| Renin-angiotensin system | |||||
| Hematopoietic cell lineage | |||||
| Pathway Interaction Database | C-MYB transcription factor network | ||||
| PathWhiz Pathway | Glutathione Metabolism | ||||
| Reactome | Metabolism of Angiotensinogen to Angiotensins | ||||
| WikiPathways | Metabolism of Angiotensinogen to Angiotensins | ||||
| Cardiac Progenitor Differentiation | |||||
| miR-targeted genes in squamous cell - TarBase | |||||
| miR-targeted genes in muscle cell - TarBase | |||||
| miR-targeted genes in lymphocytes - TarBase | |||||
| miR-targeted genes in leukocytes - TarBase | |||||
| Glutathione metabolism | |||||
| References | |||||
| REF 1 | J Med Chem. 2007 Mar 22;50(6):1322-34. Epub 2007 Feb 28.Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.